web statisticsweb statistics Consumer Alert: Recall Issued on Bottles of Amazon Basic Care Pain Relievers – Breitbart News
October 19, 2026
Tech

Consumer Alert: Recall Issued on Bottles of Amazon Basic Care Pain Relievers

Amazon has pulled more than 112,000 bottles of its Amazon Basic Care extra-strength acetaminophen after customers reported the tablets turned an unusual color. The New York Post reports that the FDA recall covers Amazon Basic Care Extra Strength Pain Relief acetaminophen 500mg caplets, made in…

Posted on 1 min read

Amazon has pulled more than 112,000 bottles of its Amazon Basic Care extra-strength acetaminophen after customers reported the tablets turned an unusual color.

\n\n

The New York Post reports that the FDA recall covers Amazon Basic Care Extra Strength Pain Relief acetaminophen 500mg caplets, made in India by Aurohealth and distributed by Amazon.com Services LLC, which is based in Seattle. The FDA says the recall is ongoing.

\n\n

Discoloration is what triggered the recall, but the FDA hasn’t said what caused it, and it hasn’t described any specific health risks or injuries linked to the affected bottles.

\n\n

In total, 112,932 bottles are affected across three package sizes: 14,640 bottles of 200 caplets, 90,456 bottles of 500 caplets, and 7,836 bottles of 1,000 caplets. The recalled lot numbers are ACD125040A for the 200-count bottles; ACD124036A, ACD124030A, ACD124042A, ACD124048B and ACD125010A for the 500-count bottles; and ACD124048A for the 1,000-count bottles.

\n\n

An Amazon spokesperson confirmed the recall to Fox Business, saying, “Amazon is voluntarily recalling specific lots of Amazon Basic Care Extra Strength Pain Relief acetaminophen 500mg caplets due to reports of tablet discoloration in the affected lots.” The spokesperson added that the action was coordinated with regulators and the manufacturer: “This is a…

Original source: https://www.breitbart.com/tech/

Disclaimer: This article is based on reporting originally published by Breitbart News. Breitbart News does not claim ownership of the original reporting and has republished or summarized this content for informational and commentary purposes only. For the full original report, please visit Breitbart.com .

Leave a Reply

Your email address will not be published. Required fields are marked *